Horizon Quantum Holdings Ltd. has taken a significant step in the quantum computing sector by announcing a non-binding letter of intent to acquire Entropica Labs Pte. Ltd. The proposed acquisition, valued at $27 million, will be paid in the form of Horizon Quantum's Class A ordinary shares. This move is expected to bolster Horizon's software infrastructure capabilities, enhancing its position in the rapidly evolving field of quantum applications.
The announcement was made on November 5, 2026, and the transaction is contingent upon the completion of due diligence, related audits, and the signing of definitive agreements. This acquisition reflects Horizon Quantum's commitment to expanding its technological capabilities and market presence.
Background
Horizon Quantum Holdings Ltd., listed on Nasdaq under the ticker symbols HQ and HQWWW, operates in the computer programming services sector (SIC 7371). The company, founded in 2018 by Dr. Joe Fitzsimons, focuses on developing software infrastructure for quantum applications. Horizon Quantum aims to bridge the gap between current quantum hardware and future applications, providing developers with advanced tools to tackle complex computational problems.
What the Filing Says
According to the SEC filing, "On November 5, 2026, Horizon Quantum Holdings, Ltd. issued a press release announcing that the Company entered into a non-binding letter of intent to acquire Entropica Labs Pte. Ltd., a Singapore private company limited by shares." The filing further details that the transaction is subject to customary conditions, including due diligence and audits.
Impact
This acquisition may significantly impact both companies involved. For Horizon Quantum, acquiring Entropica Labs could enhance its software offerings, particularly in error correction and fault tolerance, which are critical areas in quantum computing. Entropica Labs, founded by former researchers at the Centre for Quantum Technologies, specializes in developing software that enables quantum hardware to run error-corrected programs efficiently.
What's Next
The filing does not say what happens next, but the completion of the acquisition will depend on the successful negotiation of definitive agreements and the satisfaction of customary conditions.
Read Next
Cabaletta Bio reports Q3 results, highlights financial metrics
Marex Group Reports Record Q3 2026 Results with Strong Growth
Genie Energy reports Q3 2026 results with mixed performance
Palvella Therapeutics reports Q3 2026 financial results
Curtiss-Wright Reports Strong Q3 Results, Raises Guidance
Nextdoor Reports Strong Q3 2026 Results, Narrows Net Loss




